Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study

Human Reproduction

Volumn 20, Issue 11, 2005, Pages 3198-3203

  Papanikolaou, Evangelos G ^a   D'haeseleer, Elke ^a   Verheyen, Greta ^a   Van de Velde, Hilde ^a   Camus, Michael ^a   Van Steirteghem, Andre ^a   Devroey, Paul ^a   Tournaye, Herman ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

Blastocyst; Cleavage stage embryo; Embryo transfer; GnRH antagonist; Pregnancy rate

Indexed keywords

GONADORELIN AGONIST; GONADORELIN ANTAGONIST;

ADULT; ARTICLE; BIRTH RATE; BLASTOCYST; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; NIDATION; OOCYTE CLEAVAGE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TWIN PREGNANCY;

EID: 27944445460     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dei217     Document Type: Article

References (22)

1. Blake DA, Proctor M and Johnson NP (2004) The merits of blastocyst versus cleavage stage embryo transfer: A Cochrane review. Hum Reprod 19,795-807.
2. Bungum M, Bungum L, Humaidan P and Yding Andersen C (2003) Day 3 versus day 5 embryo transfer: A prospective randomized study. Reprod Biomed Online 7,98-104.
3. Coskun S, Hollanders J, Al-Hassan S, Al-Sufyan H, Al-Mayman H and Jaroudi K (2000) Day 5 versus day 3 embryo transfer: A controlled randomized trial. Hum Reprod 15,1947-1952.
4. Gardner DK and Schoolcraft WB (1999) In vitro culture of human blastocysts. In: Jansen R, Mortimer D (eds) Towards reproductive certainty: Infertility and genetics beyond 1999. Carnforth: Parthenon Press, 378-388.
5. Gardner DK, Lane M and Schoolcraft WB (2000) Culture and transfer of viable blastocysts: A feasible proposition for human IVF. Hum Reprod 15(Suppl 6):9-23.
6. Gardner DK, Surrey E, Minjarez D, Leitz A, Stevens J and Schoolcraft WB (2004) Single blastocyst transfer: A prospective randomized trial. Fertil Steril 81,551-555.
7. Jones GM, Trounson AO, Gardner DK, Kausche A, Lolatgis N and Wood C (1998a) Evolution of a culture protocol for successful blastocyst development and pregnancy. Hum Reprod 13,169-177.
8. Jones GM, Trounson AO, Lolatgis N, Wood C (1998b) Factors affecting the success of human blastocyst development and pregnancy following in vitro fertilization and embryo transfer. Fertil Steril 70, 1022-1029.
9. Kolibianakis EM, Zikopoulos K, Verpoest W, Camus M, Joris H, Van Steirteghem AC and Devroey P (2004) Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer? Hum Reprod 19,2550-2554.
10. Magli MC, Jones GM, Gras L, Gianaroli L, Korman I and Trounson AO (2000) Chromosome mosaicism in day 3 aneuploid embryos that develop to morphologically normal blastocysts in vitro. Hum Reprod 15,1781-1786.
11. Milki AA, Hinckley MD, Fisch JD, Dasig D and Behr B (2000) Comparison of blastocyst transfer with day 3 embryo transfer in similar patient populations. Fertil Steril 73,126-129.
12. Munne S and Cohen J (1998) Chromosome abnormalities in human embryos. Hum Reprod Update 4,842-855.
13. Papanikolaou EG, Bourgain C, Kolibianakis E, Tournaye H and Devroey P (2005a) Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes. Hum Reprod Feb 10 [Epub ahead of print].
14. Papanikolaou EG, Tournaye H, Verpoest W, Camus M, Vernaeve V, Van Steirteghem A and Devroey P (2005b) Early and late ovarian hyperstimulation syndrome: Early pregnancy outcome and profile. Hum Reprod 20,636-641.
15. Racowsky C, Jackson KV, Cekleniak NA, Fox JH, Hornstein MD and Ginsburg ES (2000) The number of eight-cell embryos is a key determinant for selecting day 3 or day 5 transfer. Fertil Steril 73,558-564.
16. Rienzi L, Ubaldi F, Iacobelli M, Ferrero S, Minasi MG, Martinez F, Tesarik J and Greco E (2002) Day 3 embryo transfer with combined evaluation at the pronuclear and cleavage stages compares favourably with day 5 blastocyst transfer. Hum Reprod 17,1852-1855.
17. Rijnders PM and Jansen CA (1998) The predictive value of day 3 embryo morphology regarding blastocyst formation, pregnancy and implantation rate after day 5 transfer following in-vitro fertilization or intracytoplasmic sperm injection. Hum Reprod 13,2869-2873.
18. Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, Devroey P, Liebaers I and Van Steirteghem A (2004) Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: A prospective randomized controlled trial. Hum Reprod 19,2849-2858.
19. Tsirigotis M (1998) Blastocyst stage transfer: Pitfalls and benefits. Too soon to abandon current practice? Hum Reprod 13,3285-9.
20. Van der Auwera I, Debrock S, Spiessens C, Afschrift H, Bakelants E, Meuleman C, Meeuwis L and D'Hooghe TM (2002) A prospective randomized study: Day 2 versus day 5 embryo transfer. Hum Reprod 17,1507-1512.
21. Van Landuyt L, De Vos A, Joris H, Verheyen G, Devroey P and Van Steirteghem A (2005) Blastocyst formation in IVF versus ICSI cycles: influence of the fertilization procedure. Fertil Steril 83,1397-1403.
22. Vidaeff AC, Racowsky C and Rayburn WF (2000) Blastocyst transfer in human in vitro fertilization. A solution to the multiple pregnancy epidemic. J Reprod Med 45,529-540.